Funder
Breast Cancer Research Foundation
H2020 European Research Council
Stand Up To Cancer
Cancer Research UK
UK Medical Research Council
Wellcome Trust
Cancer Research UK Lung Cancer Centre of Excellence
Rosetrees Trust
Butterfield and Stoneygate Trusts
Novo Nordisk UK Research Foundation
Royal Society Research Professorships Enhancement Award
National Institute for Health Research (NIHR) Biomedical Research Centre at University College London Hospitals
UCLH Biomedical Research Centre
Publisher
Public Library of Science (PLoS)
Reference12 articles.
1. Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study;PS Chauhan;PloS Med,2021
2. Utility of ctDNA in Predicting Response to Neoadjuvant Chemoradiotherapy and Prognosis Assessment in Locally Advanced Rectal Cancer: A Prospective Cohort Study;Y Wang;PloS Med,2021
3. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: a prospective cohort study;J Tie;PloS Med,2021
4. Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer;EJ Moding;Nature Cancer,2020
5. Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab;R Raja;Clinical Cancer Research,2018
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献